Century Therapeutics, Inc. (IPSC) Misses Q3 EPS by 1c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• HA Sustainable Infrastructure Ca (HASI) PT Lowered to $45 at BofA Securities